Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Abiomed, Inc.
  6. Summary
    ABMD   US0036541003

ABIOMED, INC.

(ABMD)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/27/2021 07/28/2021 07/29/2021 07/30/2021 08/02/2021 Date
321.96(c) 323.8(c) 324.81(c) 327.14(c) 331 Last
146 469 151 435 96 868 102 668 67 194 Volume
-0.94% +0.57% +0.31% +0.72% +1.18% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 1 018 M - -
Net income 2022 198 M - -
Net cash position 2022 553 M - -
P/E ratio 2022 76,2x
Yield 2022 -
Sales 2023 1 168 M - -
Net income 2023 235 M - -
Net cash position 2023 785 M - -
P/E ratio 2023 64,1x
Yield 2023 -
Capitalization 14 834 M 14 834 M -
EV / Sales 2022 14,0x
EV / Sales 2023 12,0x
Nbr of Employees 1 725
Free-Float 92,5%
More Financials
Company
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and... 
More about the company
Ratings of Abiomed, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C-
More Ratings
All news about ABIOMED, INC.
07/20ABIOMED : SVB Leerink Adjusts Price Target for Abiomed to $335 From $355, Mainta..
MT
07/15ABIOMED : First Quarter Fiscal 2022 Earnings and Conference Call Notification
BU
06/29ABIOMED : Receives FDA Pre-Market Approval for Impella Right Heart Pump
MT
06/29ABIOMED : FDA Grants Highest Level of Approval to the Next Generation of Impella..
BU
06/29Abiomed’s Receives U.S. Food and Drug Administration Pre-Market Approval as S..
CI
06/29Abiomed Heart Pump Gets FDA Pre-Market Approval
DJ
06/25ABIOMED, INC.(NASDAQGS : ABMD) added to Russell 1000 Growth-Defensive Index
CI
06/25ABIOMED, INC.(NASDAQGS : ABMD) added to Russell 1000 Defensive Index
CI
06/18ABIOMED : Deutsche Bank Starts Abiomed at Buy With $360 Price Target
MT
06/02INSIDER TRENDS : Abiomed Insider Tax Sale Continues 90-Day Selling Trend
MT
06/02INSIDER TRENDS : Insider at Abiomed Sale for Taxes Adds to 90-Day Selling Trend
MT
06/01ABIOMED : Buys Medical Device Firm preCARDIA for Undisclosed Sum
MT
06/01ABIOMED : Acquires preCARDIA, a Breakthrough Medical Device Company, to Improve ..
PU
06/01ABIOMED INC : Regulation FD Disclosure, Financial Statements and Exhibits (form ..
AQ
06/01ABIOMED : áAbiomed Acquires preCARDIA, a Breakthrough Medical Device Company, to..
BU
More news
News in other languages on ABIOMED, INC.
06/30ABIOMED : FDA erteilt höchste Zulassungsstufe für die Impella RP Herzpumpe der n..
06/29ABIOMED : La FDA octroie le niveau d'approbation le plus élevé à la prochaine gé..
06/01ABIOMED : übernimmt preCARDIA, ein bahnbrechendes Medizintechnikunternehmen, um ..
06/01ABIOMED : rachète preCARDIA, une société d'instruments médicaux innovante, dans ..
04/30ABIOMED : Endergebnisse der NCSI (National Cardiogenic Shock Initiative) - Studi..
More news
Analyst Recommendations on ABIOMED, INC.
More recommendations
Chart ABIOMED, INC.
Duration : Period :
Abiomed, Inc. Technical Analysis Chart | ABMD | US0036541003 | MarketScreener
Technical analysis trends ABIOMED, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 11
Last Close Price 327,14 $
Average target price 368,33 $
Spread / Average Target 12,6%
EPS Revisions
Managers and Directors
Michael R. Minogue Chairman, President & Chief Executive Officer
Todd A. Trapp Chief Financial Officer & Vice President
Thorsten Sie▀ Chief Technology Officer & Vice President
Charles A. Simonton Chief Medical Officer
Laxmi N. Peri Vice President-Engineering
Sector and Competitors